The Latest in Gastrointestinal Cancer

Treatment Sequence May Impact Pancreatic Cancer Survival

January 29, 2024

ctDNA’s Prognostic Strength, Low Sensitivity Seen in Studies

January 25, 2024

Dana-Farber Moves to Retract, Correct Dozens of Cancer Papers Amid Allegations

January 25, 2024

Bladder Cancer: Is Active Surveillance the Way Forward?

January 25, 2024

The Case for Biomarker Testing in Gastroesophageal Cancer

January 24, 2024

Hepatic infusion pumps: New enthusiasm for an old technology

January 24, 2024

Targeted Colorectal Cancer Combo Improves QoL

January 23, 2024

Immunotherapy Combo Wins Big on PFS in First-Line Mets CRC

January 23, 2024

No Compelling Evidence of Pancreatic Cancer Risk With GLP-1s

January 23, 2024

Gastrointestinal Cancer

Radiation Oncologists Fight for Payment Reform Amid Cuts

January 19, 2024

Standard Therapy Beats Out Primary Surgery in Rectal Cancer

January 18, 2024

SUDs rates highest in head, neck, and gastric cancer survivors

January 16, 2024

FDA Rejects GI Cancer Drug Over Manufacturing Issues

January 12, 2024

Gastric Cancer Survival Differs by Race and Ethnicity

January 9, 2024

GLP-1 RAs Associated With Reduced Colorectal Cancer Risk in Patients With Type 2 Diabetes

December 19, 2023